Indian gave nod to emergency use authorization approval of Serum Institute of India (SII) and Bharat Biotech's Covid-19 vaccine last week. It is now being learned that any vaccine maker, including Pfizer, must conduct an additional local study to be considered for country's immunization programme. According to news agency Reuters, Pfizer ...
Indian gave nod to emergency use authorization approval of Serum Institute of India (SII) and Bharat Biotech’s Covid-19 vaccine last week. It is now being learned that any vaccine maker, including Pfizer, must conduct an additional local study to be considered for country’s immunization programme. According to news agency Reuters, Pfizer
More Stories
Why students of Dumka Medical College are protesting? | Ghanti Bajao
Delhi: Why teachers are not getting proper salaries yet? | Ghanti Bajao
IN PICS: Forgetting Congress’ Previous Stand, Rahul Gandhi Attends Jallikattu Event In Tamil Nadu